Unity Biotechnology Inc (UBX) is lower by Friday morning, with the stock losing -1.74% in pre-market trading to 1.69. UBX's short-term technical score of 43 indicates that the stock has traded less bullishly over the last month than 57% of stocks on the market. In the Biotechnology industry, which ranks 129 out of 146 industries, Unity Biotechnology Inc ranks higher than 63% of stocks. Unity Biotechnology Inc has remained neutral 0.00% over the past month, closing at $2.13 on November 17. During this period of time, the stock fell as low as $1.57 and as high as $2.26. UBX has an average analyst recommendation of Strong Buy. The company has an average price target of $6.50.
UBX has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on UBX!